A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

Arrowhead Pharmaceuticals, Inc. ( (ARWR)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...

Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

Farmington Hills, Michigan, Oct. 23, 2025 (GLOBE NEWSWIRE) -- “We made every effort to bring this treatment to U.S. patients first,” said Cerezen Founder and CEO Manoj Bhargava. “However, it seems ...

Find out more about a new study's promising treatment. July 29, 2008— -- More than 5 million Americans have Alzheimer's disease and 10 million baby boomers are expected to develop it in the ...